Vincent Planche

University of Bordeaux

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Scott Ayton

University of Melbourne

AUSTRALIA

View details

Thomas Tourdias

Head of the department

Bordeaux University Hospital

FRANCE

View details

Archana Singh-Manoux

Research Professor

INSERM

FRANCE

View details

Emmanuel COGNAT

Assistant Professor (MCU-PH)

Université Paris-Saclay

FRANCE

View details

Wassilios Meissner

University of Bordeaux

FRANCE

View details

Nicolas Villain

Sorbonne Université

FRANCE

View details

Julien Dumurgier

Université Paris-Saclay

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vincent Planche

Research Interests

Explore related searches

Contact this professor

Articles (20)

MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study

Lifespan Tree of Brain Anatomy: Diagnostic Values for Motor and Cognitive Neurodegenerative Diseases

Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan

Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaques

Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers

The science does not yet support regulatory approval of amyloid‐targeting therapies for Alzheimer's disease based solely on biomarker evidence

Biological definitions of synucleinopathies should be anchored in clinical trajectories and encompass the complex biology of the disease

Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics

Statistical harmonization of versions of measures across studies using external data: self-rated health and self-rated memory

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer’s disease

Lifespan neurodegeneration of the human brain in multiple sclerosis

Mnemonic Discrimination Performance in a Memory Clinic: A Pilot Study

Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort

Delirium, blood biomarkers for neurodegeneration, and dementia

Advocating for Demonstration of Disease Modification—Have We Been Approaching Clinical Trials in Early Alzheimer Disease Incorrectly?

Anatomical MRI staging of frontotemporal dementia variants

Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates

Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort

High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 2: putative scenarios and timeline in case of approval, recommendations for use, implementation, and ethical considerations in France

Collaborators (7)

Scott Ayton

Thomas Tourdias

Archana Singh-Manoux

Emmanuel COGNAT

Wassilios Meissner

Nicolas Villain

Julien Dumurgier

Make your next move.